Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological Barriers
暂无分享,去创建一个
[1] A. Tissot,et al. Versatile Virus-Like Particle Carrier for Epitope Based Vaccines , 2010, PloS one.
[2] A. Maitra,et al. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors , 2011, Cancer biology & therapy.
[3] Enzo Terreno,et al. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. , 2009, Accounts of chemical research.
[4] Peng Zhang,et al. ZnO QD@PMAA-co-PDMAEMA nonviral vector for plasmid DNA delivery and bioimaging. , 2010, Biomaterials.
[5] B. Chackerian,et al. Virus-like particles: flexible platforms for vaccine development , 2007, Expert review of vaccines.
[6] A. Santoro,et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] Q. Pankhurst,et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. , 2009, Cancer research.
[8] G. Dai,et al. Image-guided breast tumor therapy using a small interfering RNA nanodrug. , 2010, Cancer research.
[9] Kirsten Sandvig,et al. Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies , 2011 .
[10] Andreas Kjær,et al. 64Cu loaded liposomes as positron emission tomography imaging agents. , 2011, Biomaterials.
[11] W. Dalton,et al. Tumor microenvironment and drug resistance in hematologic malignancies. , 2006, Blood reviews.
[12] In-Kyu Park,et al. Multifunctional silica nanotubes for dual-modality gene delivery and MR imaging. , 2011, Biomaterials.
[13] J. Panyam,et al. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[14] Mingwu Shen,et al. Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles. , 2011, Biomaterials.
[15] Lei Xing,et al. Tomographic molecular imaging of x-ray-excitable nanoparticles. , 2010, Optics letters.
[16] Magdalena Swierczewska,et al. Inorganic Nanoparticles for Multimodal Molecular Imaging , 2011, Molecular imaging.
[17] U. Bickel,et al. Delivery of peptides and proteins through the blood-brain barrier. , 1993 .
[18] U. Mueller,et al. Metal–organic frameworks—prospective industrial applications , 2006 .
[19] Arend Heerschap,et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy , 2005, Nature Biotechnology.
[20] P. Jain,et al. Au nanoparticles target cancer , 2007 .
[21] Kenneth C. Anderson,et al. Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-Bound–Rapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma , 2010, Molecular Cancer Therapeutics.
[22] M. Bawendi,et al. Renal clearance of quantum dots , 2007, Nature Biotechnology.
[23] P. Couvreur,et al. Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance. , 1992, Biochemical pharmacology.
[24] Yuquan Wei,et al. A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] W. Oyen,et al. Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients , 2009, Clinical Cancer Research.
[26] Peter van Gelderen,et al. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells , 2001, Nature Biotechnology.
[27] R. Weissleder,et al. Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles , 2006, Nature Protocols.
[28] P. Jain,et al. Universal scaling of plasmon coupling in metal nanostructures: extension from particle pairs to nanoshells. , 2007, Nano letters.
[29] K. Landfester,et al. Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. , 2008, Macromolecular bioscience.
[30] C. Pui,et al. The tumor lysis syndrome. , 2011, The New England journal of medicine.
[31] C. Meltzer,et al. PET/CT: form and function. , 2007, Radiology.
[32] C. Montero-Menei,et al. The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. , 2011, Biomaterials.
[33] T. Scheenen,et al. Sensitivity of magnetic resonance imaging of dendritic cells for in vivo tracking of cellular cancer vaccines , 2006, International journal of cancer.
[34] Vladimir P Torchilin,et al. Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[35] D. Figgitt,et al. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. , 2003, Drugs.
[36] Russell J Mumper,et al. Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. , 2009, Cancer research.
[37] Miqin Zhang,et al. Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties and in vivo behavior. , 2010, Nanomedicine.
[38] Y. Mao,et al. In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging. Laboratory investigation. , 2008, Journal of neurosurgery.
[39] Hong Ding,et al. Imaging pancreatic cancer using bioconjugated InP quantum dots. , 2009, ACS nano.
[40] Ralph Weissleder,et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy , 2009, Proceedings of the National Academy of Sciences.
[41] Roland Felix,et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma , 2006, Journal of Neuro-Oncology.
[42] R. Gurny,et al. Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[43] R. Wagner,et al. Virus-like particles—universal molecular toolboxes , 2007, Current Opinion in Biotechnology.
[44] G T Gillies,et al. Distribution of macromolecular dyes in brain using positive pressure infusion: a model for direct controlled delivery of therapeutic agents. , 1998, Surgical neurology.
[45] N. Hijnen,et al. Magnetic resonance imaging of high intensity focused ultrasound mediated drug delivery from temperature-sensitive liposomes: an in vivo proof-of-concept study. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[46] Miqin Zhang,et al. pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells. , 2010, Molecular pharmaceutics.
[47] Kazuo Maruyama,et al. Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. , 2011, Advanced drug delivery reviews.
[48] P. Perriat,et al. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging. , 2007, Journal of the American Chemical Society.
[49] G. Krishnamoorthy,et al. Intracellular dynamics of the gene delivery vehicle polyethylenimine during transfection: investigation by two-photon fluorescence correlation spectroscopy. , 2003, Biochimica et biophysica acta.
[50] M. Dewhirst,et al. Chemodosimetry of in vivo tumor liposomal drug concentration using MRI , 2006 .
[51] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[52] W. Lu,et al. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. , 2005, International journal of pharmaceutics.
[53] Z. Fayad,et al. A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging. , 2010, Contrast Media & Molecular Imaging.
[54] Michael A Vogelbaum,et al. Future of convection-enhanced delivery in the treatment of brain tumors. , 2010, Future oncology.
[55] Sangjin Park,et al. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. , 2007 .
[56] A. Jimeno,et al. More than Markers: Biological Significance of Cancer Stem Cell-Defining Molecules , 2010, Molecular Cancer Therapeutics.
[57] Sung Tae Kim,et al. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. , 2007, Angewandte Chemie.
[58] Yun Zhou,et al. Pulsed ultrasound enhances nanoparticle penetration into breast cancer spheroids. , 2010, Molecular pharmaceutics.
[59] M. El-Sayed,et al. Aspect ratio dependence of the enhanced fluorescence intensity of gold nanorods: experimental and simulation study. , 2005, The journal of physical chemistry. B.
[60] Yusuke Nakamura,et al. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. , 2003, Biochemical and biophysical research communications.
[61] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[62] Volker Sturm,et al. Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma , 2003, Annals of neurology.
[63] Hans Clevers,et al. The cancer stem cell: premises, promises and challenges , 2011, Nature Medicine.
[64] R. Carroll,et al. Human Bone Marrow‐Derived Mesenchymal Stromal Cells Expressing S‐TRAIL as a Cellular Delivery Vehicle for Human Glioma Therapy , 2009, Stem cells.
[65] Forrest M Kievit,et al. Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. , 2011, Advanced drug delivery reviews.
[66] S. Gartler,et al. Clonal origin of chronic myelocytic leukemia in man. , 1967, Proceedings of the National Academy of Sciences of the United States of America.
[67] Martin F. Bachmann,et al. The coming of age of virus-like particle vaccines , 2008, Biological chemistry.
[68] Xiaoxia Du,et al. Silica‐Coated Manganese Oxide Nanoparticles as a Platform for Targeted Magnetic Resonance and Fluorescence Imaging of Cancer Cells , 2010 .
[69] L. Neckers,et al. Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. , 2009, The Journal of clinical investigation.
[70] Dong Liang,et al. A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. , 2010, Journal of the American Chemical Society.
[71] Wendy F. Liu,et al. Development of Cationic Polymer Coatings to Regulate Foreign‐Body Responses , 2011, Advanced materials.
[72] Lothar Lilge,et al. The Distribution of the Anticancer Drug Doxorubicin in Relation to Blood Vessels in Solid Tumors , 2005, Clinical Cancer Research.
[73] K. Iwai,et al. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. , 1989, Science.
[74] S. Caruthers,et al. Conquering the dark side: colloidal iron oxide nanoparticles. , 2009, ACS nano.
[75] Vincent M. Rotello,et al. Tuning Payload Delivery in Tumour Cylindroids using Gold Nanoparticles , 2010, Nature nanotechnology.
[76] J. Milbrandt,et al. Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. , 2010, Biomaterials.
[77] N. Gu,et al. Effective PEGylation of Iron Oxide Nanoparticles for High Performance In Vivo Cancer Imaging , 2011 .
[78] E. Jaffee,et al. Use of tumour-responsive T cells as cancer treatment , 2009, The Lancet.
[79] D. Townsend. Multimodality imaging of structure and function , 2008, Physics in medicine and biology.
[80] Mark E. Davis,et al. Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.
[81] H. McMahon,et al. Mechanisms of endocytosis. , 2009, Annual review of biochemistry.
[82] H. Kasamatsu,et al. The carboxyl 35 amino acids of SV40 Vp3 are essential for its nuclear accumulation. , 1987, Virology.
[83] Wenbin Lin,et al. Surfactant-assisted synthesis of nanoscale gadolinium metal-organic frameworks for potential multimodal imaging. , 2008, Angewandte Chemie.
[84] Chad A Mirkin,et al. Colloidal gold and silver triangular nanoprisms. , 2009, Small.
[85] Xiaogang Peng. Band gap and composition engineering on a nanocrystal (BCEN) in solution. , 2010, Accounts of chemical research.
[86] S. Laurent,et al. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics. , 2011, Nanomedicine.
[87] Jerry S. H. Lee,et al. Magnetic nanoparticles in MR imaging and drug delivery. , 2008, Advanced drug delivery reviews.
[88] Teodor Veres,et al. Polyethylene glycol-covered ultra-small Gd2O3 nanoparticles for positive contrast at 1.5 T magnetic resonance clinical scanning , 2007 .
[89] Jangwook P. Jung,et al. A self-assembling peptide acting as an immune adjuvant , 2009, Proceedings of the National Academy of Sciences.
[90] P. Dirks,et al. Cancer stem cells in nervous system tumors , 2004, Oncogene.
[91] Arutselvan Natarajan,et al. Thermal dosimetry predictive of efficacy of 111In-ChL6 nanoparticle AMF--induced thermoablative therapy for human breast cancer in mice. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[92] Helen Y Wang,et al. Regulatory T cells and cancer. , 2007, Current opinion in immunology.
[93] Taeghwan Hyeon,et al. Inorganic Nanoparticles for MRI Contrast Agents , 2009 .
[94] Warren C W Chan,et al. Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.
[95] Philip S Low,et al. In vitro and in vivo two-photon luminescence imaging of single gold nanorods. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[96] Sylvain Martel,et al. Magnetic microparticle steering within the constraints of an MRI system: proof of concept of a novel targeting approach , 2007, Biomedical microdevices.
[97] Christopher R. So,et al. Chemically self-assembled antibody nanorings (CSANs): design and characterization of an anti-CD3 IgM biomimetic. , 2010, Journal of the American Chemical Society.
[98] Roger Y Tsien,et al. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[99] D. Luo,et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. , 2008, Biomaterials.
[100] M. D. Rowe,et al. Synthesis of gadolinium nanoscale metal-organic framework with hydrotropes: manipulation of particle size and magnetic resonance imaging capability. , 2011, ACS applied materials & interfaces.
[101] V. Torchilin,et al. Micellar Nanocarriers: Pharmaceutical Perspectives , 2006, Pharmaceutical Research.
[102] Edouard C. Nice,et al. Bypassing Multidrug Resistance in Cancer Cells with Biodegradable Polymer Capsules , 2010, Advanced materials.
[103] Mu-Yi Hua,et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain , 2010, Proceedings of the National Academy of Sciences.
[104] C. Contag,et al. Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation. , 2005, The American journal of pathology.
[105] Xueyuan Chen,et al. Upconversion nanoparticles in biological labeling, imaging, and therapy. , 2010, The Analyst.
[106] D. Sept,et al. Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging , 2008, Magnetic resonance in medicine.
[107] A. Seiter,et al. Identification of domains involved in nuclear uptake and histone binding of protein N1 of Xenopus laevis. , 1988, The EMBO journal.
[108] Yue-Wern Huang,et al. Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism. , 2011, Biomaterials.
[109] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[110] David A. Gough,et al. Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[111] Giampietro Schiavo,et al. A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins , 2010, Nature Reviews Microbiology.
[112] Carl G. Figdor,et al. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting , 2007, Nature Reviews Immunology.
[113] J. Rhim,et al. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. , 2007, Cancer research.
[114] D. P. O'Neal,et al. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. , 2004, Cancer letters.
[115] L. Mariani,et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment , 2009, Proceedings of the National Academy of Sciences.
[116] Frank O. Nestle,et al. Dendritic cells: On the move from bench to bedside , 2001, Nature Medicine.
[117] Hong Yuan,et al. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. , 2009, Biomaterials.
[118] Clara L Santos-Cuevas,et al. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression. , 2011, Bioconjugate chemistry.
[119] Chen Jiang,et al. The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain. , 2008, Biomaterials.
[120] Raoul Kopelman,et al. Targeted gold nanoparticles enable molecular CT imaging of cancer. , 2008, Nano letters.
[121] Forrest M Kievit,et al. Doxorubicin loaded iron oxide nanoparticles overcome multidrug resistance in cancer in vitro. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[122] J. Dick,et al. Stem cell concepts renew cancer research. , 2008, Blood.
[123] Daniel W. Pack,et al. Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.
[124] King-Jen Chang,et al. Multiple Lineages of Human Breast Cancer Stem/Progenitor Cells Identified by Profiling with Stem Cell Markers , 2009, PloS one.
[125] C. Won,et al. PEG-modified biopharmaceuticals , 2009 .
[126] Lei Xing,et al. Synthesis and Radioluminescence of PEGylated Eu3+‐doped Nanophosphors as Bioimaging Probes , 2011, Advanced materials.
[127] G. Warnock,et al. Potential implications of mesenchymal stem cells in cancer therapy. , 2011, Cancer letters.
[128] T. Whiteside,et al. Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. , 2006, Seminars in cancer biology.
[129] S. Rosenberg,et al. Adoptive cell transfer: a clinical path to effective cancer immunotherapy , 2008, Nature Reviews Cancer.
[130] Xin Wang,et al. High-photoluminescence-yield gold nanocubes: for cell imaging and photothermal therapy. , 2010, ACS nano.
[131] D. Altieri,et al. Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network , 2007, Cell.
[132] Sungho Jin,et al. Magnetic nanoparticles for theragnostics. , 2009, Advanced drug delivery reviews.
[133] Kevin Brindle,et al. New approaches for imaging tumour responses to treatment , 2008, Nature Reviews Cancer.
[134] J. Mathis,et al. Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma , 2007, Breast Cancer Research and Treatment.
[135] P. Tam,et al. Conjugation of latent membrane protein (LMP)-2 epitope to gold nanoparticles as highly immunogenic multiple antigenic peptides for induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses in vitro. , 2009, Bioconjugate chemistry.
[136] Kazuo Maruyama,et al. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.
[137] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[138] M. Allendorf,et al. Metal‐Organic Frameworks: A Rapidly Growing Class of Versatile Nanoporous Materials , 2011, Advanced materials.
[139] Jianhai Yang,et al. Cationic polymer brush grafted-nanodiamond via atom transfer radical polymerization for enhanced gene delivery and bioimaging , 2011 .
[140] M. Prato,et al. Chemistry of carbon nanotubes. , 2006, Chemical reviews.
[141] A. Puisieux,et al. Metastasis: a question of life or death , 2006, Nature Reviews Cancer.
[142] Te-Jen Ma,et al. Design, synthesis, and imaging of an activatable photoacoustic probe. , 2010, Journal of the American Chemical Society.
[143] M. Noble,et al. Cancer stem cells. , 2006, The New England journal of medicine.
[144] P. Ajayan,et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation , 2009, Proceedings of the National Academy of Sciences.
[145] G. Dai,et al. Novel membrane‐permeable contrast agent for brain tumor detection by MRI , 2010, Magnetic resonance in medicine.
[146] Warren C W Chan,et al. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.
[147] M. Prato,et al. Functionalized carbon nanotubes in drug design and discovery. , 2008, Accounts of chemical research.
[148] Forrest M Kievit,et al. PEI–PEG–Chitosan‐Copolymer‐Coated Iron Oxide Nanoparticles for Safe Gene Delivery: Synthesis, Complexation, and Transfection , 2009, Advanced functional materials.
[149] Sanjiv S Gambhir,et al. Self-illuminating quantum dot conjugates for in vivo imaging , 2006, Nature Biotechnology.
[150] M. Rosen,et al. Finding Fluorescent Needles in the Cardiac Haystack: Tracking Human Mesenchymal Stem Cells Labeled with Quantum Dots for Quantitative In Vivo Three‐Dimensional Fluorescence Analysis , 2007, Stem cells.
[151] Miqin Zhang,et al. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. , 2009, Cancer research.
[152] Sylvain Martel,et al. Steering of aggregating magnetic microparticles using propulsion gradients coils in an MRI Scanner , 2010, Magnetic resonance in medicine.
[153] Zhi-Gang Chen,et al. Synthesis, characterization, and in vivo targeted imaging of amine-functionalized rare-earth up-converting nanophosphors. , 2009, Biomaterials.
[154] J. Benoit,et al. Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. , 2009, Biomaterials.
[155] J. Karp,et al. Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .
[156] K. Ulbrich,et al. HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release. , 2010, Molecular pharmaceutics.
[157] Ueli Aebi,et al. A Nonadjuvanted Polypeptide Nanoparticle Vaccine Confers Long-Lasting Protection against Rodent Malaria1 , 2009, The Journal of Immunology.
[158] P. Couvreur,et al. Nanocarriers’ entry into the cell: relevance to drug delivery , 2009, Cellular and Molecular Life Sciences.
[159] Chitta Ranjan Patra,et al. Gold Nanoparticles Inhibit the Proliferation of Multiple Myeloma Cells , 2007 .
[160] Kazunori Kataoka,et al. PEGylated Nanoparticles for Biological and Pharmaceutical Applications , 2003 .
[161] L Xing,et al. Hybrid x-ray/optical luminescence imaging: characterization of experimental conditions. , 2010, Medical physics.
[162] Yan Zhang,et al. Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[163] T. Takeuchi,et al. Receptor-mediated transport of lactoferrin into the cerebrospinal fluid via plasma in young calves. , 2003, The Journal of veterinary medical science.
[164] Nishanth Krishnamurthy,et al. Optical imaging and magnetic field targeting of magnetic nanoparticles in tumors. , 2010, ACS nano.
[165] K. Watkin,et al. Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles. , 2006, Academic radiology.
[166] Forrest M Kievit,et al. Magnetite Nanoparticles for Medical MR Imaging. , 2011, Materials today.
[167] W John,et al. Inductive heating of ferrimagnetic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia , 2009, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[168] Robert A. Weinberg,et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model , 2010, Nature Biotechnology.
[169] Sangjin Park,et al. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo. , 2008, Angewandte Chemie.
[170] Younan Xia,et al. Gold Nanocages: Engineering Their Structure for Biomedical Applications , 2005 .
[171] Nastassja A. Lewinski,et al. T cells enhance gold nanoparticle delivery to tumors in vivo , 2011, Nanoscale research letters.
[172] Werner Treptow,et al. Affinity of C60 neat fullerenes with membrane proteins: a computational study on potassium channels. , 2010, ACS nano.
[173] I. Tannock,et al. The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. , 2006, Cancer research.
[174] Mark E. Davis,et al. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles , 2009, Proceedings of the National Academy of Sciences.
[175] Joseph M. Fox,et al. Tetrazine ligation: fast bioconjugation based on inverse-electron-demand Diels-Alder reactivity. , 2008, Journal of the American Chemical Society.
[176] R. Rossin,et al. SYNFORM ISSUE 2010/9 , 2010, Angewandte Chemie.
[177] Huajian Gao,et al. Mechanics of receptor-mediated endocytosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[178] R Weissleder,et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. , 1989, AJR. American journal of roentgenology.
[179] Sai T Reddy,et al. Exploiting lymphatic transport and complement activation in nanoparticle vaccines , 2007, Nature Biotechnology.
[180] K. Arihiro,et al. Tumor-driven evolution of immunosuppressive networks during malignant progression. , 2006, Cancer research.
[181] Mark E. Davis,et al. Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements , 2009, Proceedings of the National Academy of Sciences.
[182] Michael V. Green,et al. Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. , 2002, Journal of immunological methods.
[183] Elodie Boisselier,et al. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.
[184] C. Hadjipanayis,et al. EGFRvIII antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. , 2010, Cancer research.
[185] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[186] G. Wong,et al. Arginine‐rich cell‐penetrating peptides , 2010, FEBS letters.
[187] J. Drewe,et al. Endocytosis and Transcytosis of an Immunoliposome-Based Brain Drug Delivery System , 2000, Journal of drug targeting.
[188] A Heerschap,et al. Imaging of cellular therapies. , 2010, Advanced drug delivery reviews.
[189] Xiaohua Huang,et al. Noble metals on the nanoscale: optical and photothermal properties and some applications in imaging, sensing, biology, and medicine. , 2008, Accounts of chemical research.
[190] J. Thompson,et al. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[191] H. Kantarjian,et al. Phase 1 multicenter study of vincristine sulfate liposomes injection and dexamethasone in adults with relapsed or refractory acute lymphoblastic leukemia , 2009, Cancer.
[192] H. Bock,et al. Lipoprotein receptors in the nervous system. , 2002, Annual review of biochemistry.
[193] Wei Qian,et al. Cancer cells assemble and align gold nanorods conjugated to antibodies to produce highly enhanced, sharp, and polarized surface Raman spectra: a potential cancer diagnostic marker. , 2007, Nano letters.
[194] R. Weissleder,et al. Tetrazine-based cycloadditions: application to pretargeted live cell imaging. , 2008, Bioconjugate chemistry.
[195] M. Gumbleton,et al. Endocytosis at the blood–brain barrier: From basic understanding to drug delivery strategies , 2006, Journal of drug targeting.
[196] Wolfgang A. Weber,et al. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.
[197] Ralph Weissleder,et al. Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. , 2009, Angewandte Chemie.
[198] Lei Xing,et al. X-Ray Luminescence Computed Tomography via Selective Excitation: A Feasibility Study , 2010, IEEE Transactions on Medical Imaging.
[199] F. Szoka,et al. Retro-convection enhanced delivery to increase blood to brain transfer of macromolecules , 2007, Brain Research.
[200] Hakho Lee,et al. Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection. , 2010, Nature nanotechnology.
[201] Lihong V. Wang,et al. In vivo photoacoustic tomography of chemicals: high-resolution functional and molecular optical imaging at new depths. , 2010, Chemical reviews.
[202] Rong Wang,et al. Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.
[203] Chad A Mirkin,et al. Gold nanoparticles for biology and medicine. , 2010, Angewandte Chemie.
[204] E. Neuwelt,et al. Improving Drug Delivery to Intracerebral Tumor and Surrounding Brain in a Rodent Model: A Comparison of Osmotic versus Bradykinin Modification of the Blood-Brain and/or Blood-Tumor Barriers , 1998 .
[205] W. Gelbart,et al. Adhesion and Wrapping in Colloid−Vesicle Complexes , 2002 .
[206] J. Meng,et al. Multi-walled carbon nanotubes suppress potassium channel activities in PC12 cells , 2009, Nanotechnology.
[207] M. Matúšková,et al. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells. , 2010, Cancer letters.
[208] R. Jain,et al. Delivering nanomedicine to solid tumors , 2010, Nature Reviews Clinical Oncology.
[209] K. Camphausen,et al. Brain metastases as preventive and therapeutic targets , 2011, Nature Reviews Cancer.
[210] R. Weissleder,et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. , 2003, Cancer research.
[211] C. Dang,et al. Identification of the human c-myc protein nuclear translocation signal , 1988, Molecular and cellular biology.
[212] R. Lyons,et al. Pentapeptide nuclear localization signal in adenovirus E1a , 1987, Molecular and cellular biology.
[213] R. Weissleder,et al. Imaging in the era of molecular oncology , 2008, Nature.
[214] B. Böttcher,et al. Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[215] Jin Xie,et al. Nanoparticle-based theranostic agents. , 2010, Advanced drug delivery reviews.
[216] M. Bassik,et al. DNA vector chemistry: The covalent attachment of signal peptides to plasmid DNA , 1998, Nature Biotechnology.
[217] Miqin Zhang,et al. Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI. , 2006, Journal of biomedical materials research. Part A.
[218] C. D. Salcido,et al. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics , 2008, Breast Cancer Research.
[219] P. Allavena,et al. Role of tumor-associated macrophages in tumor progression and invasion , 2006, Cancer and Metastasis Reviews.
[220] I. Tannock,et al. Drug penetration in solid tumours , 2006, Nature Reviews Cancer.
[221] Gang Bao,et al. Shedding light on the dynamics of endocytosis and viral budding. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[222] J. Fraser Stoddart,et al. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. , 2010, Journal of the American Chemical Society.
[223] Mansoor M. Amiji,et al. Inhibition of ABCB1 (MDR1) Expression by an siRNA Nanoparticulate Delivery System to Overcome Drug Resistance in Osteosarcoma , 2010, PloS one.
[224] Patrick Couvreur,et al. Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. , 2005, Bioconjugate chemistry.
[225] Patrick Soon-Shiong,et al. Protein nanoparticles as drug carriers in clinical medicine. , 2008, Advanced drug delivery reviews.
[226] J. Panyam,et al. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. , 2006, International journal of pharmaceutics.
[227] Forrest M Kievit,et al. Chlorotoxin bound magnetic nanovector tailored for cancer cell targeting, imaging, and siRNA delivery. , 2010, Biomaterials.
[228] W. Cai,et al. Specific targeting of gliomas with multifunctional superparamagnetic iron oxide nanoparticle optical and magnetic resonance imaging contrast agents , 2007, Acta Pharmacologica Sinica.
[229] T. Whiteside. The tumor microenvironment and its role in promoting tumor growth , 2008, Oncogene.
[230] Yongdoo Choi,et al. Gold nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. , 2011, ACS nano.
[231] W. Olbricht,et al. Retro-Convection Enhanced Drug Delivery: A Computational Study , 2010, Annals of Biomedical Engineering.
[232] Taeghwan Hyeon,et al. Mesoporous Silica-Coated Hollow Manganese Oxide Nanoparticles as Positive T1 Contrast Agents for Labeling and MRI Tracking of Adipose-Derived Mesenchymal Stem Cells , 2011, Journal of the American Chemical Society.
[233] J. Frangioni,et al. Annexin A2 Is a Molecular Target for TM601, a Peptide with Tumor-targeting and Anti-angiogenic Effects , 2009, The Journal of Biological Chemistry.
[234] Maohong Fan,et al. Charge‐Reversal Drug Conjugate for Targeted Cancer Cell Nuclear Drug Delivery , 2009 .
[235] S. Ivy,et al. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways , 2011, Nature Reviews Clinical Oncology.
[236] Paul Mulvaney,et al. Drastic reduction of plasmon damping in gold nanorods. , 2002 .
[237] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[238] Forrest M Kievit,et al. Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery. , 2011, Biomaterials.
[239] M. Matúšková,et al. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice , 2008, The journal of gene medicine.
[240] Miqin Zhang,et al. Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[241] M. Giacca,et al. Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[242] Zafar Iqbal,et al. Single-walled Carbon Nanotubes Are a New Class of Ion Channel Blockers* , 2003, Journal of Biological Chemistry.
[243] W. Mark Saltzman,et al. Nanosystems for simultaneous imaging and drug delivery to T cells , 2007, The AAPS Journal.
[244] E. Rozhkova,et al. Nanoscale Materials for Tackling Brain Cancer: Recent Progress and Outlook , 2011, Advanced materials.
[245] A. Mikos,et al. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[246] S. Caruthers,et al. Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions , 2010, Angiogenesis.
[247] M. Reddish,et al. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. , 1998, Bioconjugate chemistry.
[248] D. Roberts,et al. CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer , 2009, Stem cells.
[249] Miqin Zhang,et al. Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. , 2010, Advanced drug delivery reviews.
[250] M. Prato,et al. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. , 2006, Advanced drug delivery reviews.
[251] P. Wick,et al. Carbon nanotubes - curse or blessing. , 2011, Current medicinal chemistry.
[252] P F Morrison,et al. Convection-enhanced delivery of macromolecules in the brain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[253] Joel I. Pritchard,et al. The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. , 2008, Cancer research.
[254] Jean-Christophe Ginefri,et al. In vivo single cell detection of tumor‐infiltrating lymphocytes with a clinical 1.5 Tesla MRI system , 2008, Magnetic resonance in medicine.
[255] Warren D. Foltz,et al. MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposome. , 2011, Biomaterials.
[256] J. Fletcher,et al. ABC transporters in cancer: more than just drug efflux pumps , 2010, Nature Reviews Cancer.
[257] J. Benoit,et al. In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy , 2010, Journal of Neuro-Oncology.
[258] Katherine W Ferrara,et al. Lipid-shelled vehicles: engineering for ultrasound molecular imaging and drug delivery. , 2009, Accounts of chemical research.
[259] Conroy Sun,et al. Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles. , 2008, Small.
[260] Forrest M Kievit,et al. A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells. , 2009, Biomaterials.
[261] Sandeep Arora,et al. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133. , 2010, Radiology.
[262] J Folkman,et al. Transplacental carcinogenesis by stilbestrol. , 1971, The New England journal of medicine.
[263] Wagner,et al. Application of membrane-active peptides for nonviral gene delivery. , 1999, Advanced drug delivery reviews.
[264] Fabian Kiessling,et al. Polymeric nanomedicines for image-guided drug delivery and tumor-targeted combination therapy , 2010 .
[265] Ajay Kumar Gupta,et al. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.
[266] F. Sesti,et al. Irreversible blocking of ion channels using functionalized single-walled carbon nanotubes , 2005 .
[267] Felix Kratz,et al. Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[268] Claudia Calcagno,et al. Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer. , 2011, ACS nano.
[269] F. Szoka,et al. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery. , 2004, Advanced drug delivery reviews.
[270] Jeffrey M. Rosen,et al. The Increasing Complexity of the Cancer Stem Cell Paradigm , 2009, Science.
[271] D. Davies,et al. TRAIL-expressing mesenchymal stem cells kill the putative cancer stem cell population , 2010, British Journal of Cancer.
[272] Jinwoo Cheon,et al. Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. , 2005, Journal of the American Chemical Society.
[273] S. Geary,et al. Nanoparticle Delivery Systems in Cancer Vaccines , 2011, Pharmaceutical Research.
[274] S. Martel,et al. Co-encapsulation of magnetic nanoparticles and doxorubicin into biodegradable microcarriers for deep tissue targeting by vascular MRI navigation. , 2011, Biomaterials.
[275] Yaping Li,et al. Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles. , 2011, Biomaterials.
[276] F. Szoka,et al. Convection and Retro-Convection Enhanced Delivery: Some Theoretical Considerations Related to Drug Targeting , 2010, Pharmaceutical Research.
[277] Mark W Dewhirst,et al. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. , 2007, Journal of the National Cancer Institute.
[278] S. Nie,et al. Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .
[279] Sophie Lanone,et al. Potential uses of carbon nanotubes in the medical field: how worried should patients be? , 2007, Nanomedicine.
[280] P. Humphries,et al. RNAi‐mediated reversible opening of the blood‐brain barrier , 2008, The journal of gene medicine.
[281] Forrest M Kievit,et al. Chlorotoxin labeled magnetic nanovectors for targeted gene delivery to glioma. , 2010, ACS nano.
[282] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[283] G. Schwarzer,et al. Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis. , 2007, Journal of the National Cancer Institute.
[284] J. Y. Lee,et al. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma. , 2011, Neuro-oncology.
[285] M. Jordan,et al. Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.
[286] M. Andreeff,et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. , 2002, Cancer research.
[287] D. Davies,et al. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. , 2009, Cancer research.
[288] C. El-Haibi,et al. Mesenchymal Stem Cells in the Pathogenesis and Therapy of Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.
[289] P. Black,et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[290] Forrest M Kievit,et al. PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. , 2010, ACS nano.
[291] Michael Hawkins,et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[292] A. Krešo,et al. Cancer Stem Cells and Self-renewal , 2010, Clinical Cancer Research.
[293] Xinmai Yang,et al. Molecular photoacoustic tomography with colloidal nanobeacons. , 2009, Angewandte Chemie.
[294] Y. Tabata,et al. Mesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapy. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[295] T. Mueller,et al. Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence , 2009, Journal of cellular and molecular medicine.
[296] G. Rossi,et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. , 2010, Cancer research.
[297] Jessie L.-S. Au,et al. Drug Delivery and Transport to Solid Tumors , 2003, Pharmaceutical Research.
[298] C. Heeschen,et al. Cancer stem cells in solid tumors. , 2010, Seminars in cancer biology.
[299] Peter Wust,et al. Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme , 2006, Journal of Neuro-Oncology.
[300] Miqin Zhang,et al. A pretargeted nanoparticle system for tumor cell labeling. , 2011, Molecular bioSystems.
[301] Miqin Zhang,et al. A multimodal targeting nanoparticle for selectively labeling T cells. , 2008, Small.
[302] R. Schreiber,et al. Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion , 2011, Science.
[303] C. Figdor,et al. Dendritic cell immunotherapy: mapping the way , 2004, Nature Medicine.
[304] A. Dietz,et al. Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model , 2009, Clinical Cancer Research.
[305] S. Fulda,et al. Targeting of XIAP Combined with Systemic Mesenchymal Stem Cell‐Mediated Delivery of sTRAIL Ligand Inhibits Metastatic Growth of Pancreatic Carcinoma Cells , 2010, Stem cells.
[306] P. Russell,et al. Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy? , 2010, Stem cells.
[307] Meredith A Mintzer,et al. Nonviral vectors for gene delivery. , 2009, Chemical reviews.
[308] Liang Zhao,et al. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells. , 2010, ACS nano.
[309] Michael S. Strano,et al. Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. , 2009, ACS nano.
[310] Soong Ho Um,et al. Therapeutic cell engineering using surface-conjugated synthetic nanoparticles , 2010, Nature Medicine.
[311] M. Prados,et al. A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma. , 2003, Neuro-oncology.
[312] Wei Lu,et al. Preparation and brain delivery property of biodegradable polymersomes conjugated with OX26. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[313] R. Bociek,et al. High dose intensity doxorubicin in aggressive non-Hodgkin's lymphoma: a literature-based meta-analysis. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[314] Natalia Vykhodtseva,et al. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. , 2006, Journal of neurosurgery.
[315] S. Terakawa,et al. Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy. , 2009, International journal of oncology.
[316] Mourad Tighiouart,et al. HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors. , 2009, ACS nano.
[317] Chris A Flask,et al. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. , 2008, Biomaterials.
[318] J. Bulte,et al. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. , 2009, Cancer research.
[319] T. Park,et al. Enhanced intracellular delivery of quantum dot and adenovirus nanoparticles triggered by acidic pH via surface charge reversal. , 2008, Bioconjugate chemistry.
[320] Wei Lu,et al. Targeted Photothermal Ablation of Murine Melanomas with Melanocyte-Stimulating Hormone Analog–Conjugated Hollow Gold Nanospheres , 2009, Clinical Cancer Research.
[321] G. Denardo,et al. Pharmacokinetic Characterization in Xenografted Mice of a Series of First-Generation Mimics for HLA-DR Antibody, Lym-1, as Carrier Molecules to Image and Treat Lymphoma , 2007, Journal of Nuclear Medicine.
[322] Esther H Chang,et al. Does a targeting ligand influence nanoparticle tumor localization or uptake? , 2008, Trends in biotechnology.
[323] Min-Hua Chen,et al. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model. , 2010, Nuclear medicine and biology.
[324] C. Russell Middaugh,et al. Nanotechnology in vaccine delivery☆ , 2008, Advanced Drug Delivery Reviews.
[325] A. Lu,et al. Magnetic nanoparticles: synthesis, protection, functionalization, and application. , 2007, Angewandte Chemie.
[326] Nina M. Muñoz,et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. , 2007, Cancer research.
[327] Mauro Biffoni,et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.
[328] Justin C. Grindley,et al. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery , 2009, Nature Reviews Drug Discovery.
[329] M. Raffeld,et al. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.
[330] Xiaohua Huang,et al. Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications , 2009, Advanced materials.
[331] Conroy Sun,et al. Functionalized nanoparticles with long-term stability in biological media. , 2009, Small.
[332] B. Liu,et al. Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[333] Shaoyi Jiang,et al. Novel zwitterionic-polymer-coated silica nanoparticles. , 2009, Langmuir : the ACS journal of surfaces and colloids.
[334] Andreas Hess,et al. In vivo magnetic resonance imaging of dendritic cell migration into the draining lymph nodes of mice , 2006, European journal of immunology.
[335] M. Taneichi,et al. Surface-linked liposomal antigen induces ige-selective unresponsiveness regardless of the lipid components of liposomes. , 2001, Bioconjugate chemistry.
[336] P. Schiller,et al. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. , 2010, Biomaterials.
[337] D. Busch,et al. Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer , 2007, Cancer Immunology, Immunotherapy.
[338] Qiang Wang,et al. Polyhydroxy fullerenes for non-invasive cancer imaging and therapy. , 2010, Small.
[339] K. Aboody,et al. Concise Review: Stem Cells As an Emerging Platform for Antibody Therapy of Cancer , 2010, Stem cells.
[340] L. Lejeune,et al. Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy. , 2004, Human gene therapy.
[341] C. Figdor,et al. Multimodal imaging of nanovaccine carriers targeted to human dendritic cells. , 2011, Molecular pharmaceutics.
[342] I. Ng,et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. , 2007, Gastroenterology.
[343] Ick Chan Kwon,et al. Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[344] Xingde Li,et al. Gold nanocages for cancer detection and treatment. , 2007, Nanomedicine.
[345] Donghoon Lee,et al. Optical and MRI multifunctional nanoprobe for targeting gliomas. , 2005, Nano letters.
[346] Manojit Pramanik,et al. Near infrared photoacoustic detection of sentinel lymph nodes with gold nanobeacons. , 2010, Biomaterials.
[347] J. Byrd,et al. Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia. , 2010, Molecular pharmaceutics.
[348] Ququan Wang,et al. Neurotoxin-conjugated upconversion nanoprobes for direct visualization of tumors under near-infrared irradiation. , 2010, Biomaterials.
[349] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[350] O. Mykhaylyk,et al. Glial brain tumor targeting of magnetite nanoparticles in rats , 2001 .
[351] Y. Mao,et al. DUAL‐TARGETED ANTITUMOR EFFECTS AGAINST BRAINSTEM GLIOMA BY INTRAVENOUS DELIVERY OF TUMOR NECROSIS FACTOR‐RELATED, APOPTOSIS‐INDUCING, LIGAND‐ENGINEERED HUMAN MESENCHYMAL STEM CELLS , 2009, Neurosurgery.
[352] J. Peterse,et al. Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.
[353] J. Huwyler,et al. Brain drug delivery of small molecules using immunoliposomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[354] Thomas Beyer,et al. PET/CT scanners: a hardware approach to image fusion. , 2003, Seminars in nuclear medicine.
[355] Miriam Scadeng,et al. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival , 2010, Proceedings of the National Academy of Sciences.
[356] S. Pun,et al. Bio-mimetic surface engineering of plasmid-loaded nanoparticles for active intracellular trafficking by actin comet-tail motility. , 2009, Biomaterials.
[357] Jayanth Panyam,et al. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. , 2010, Biomaterials.
[358] Leone Spiccia,et al. Nanomaterials: Applications in Cancer Imaging and Therapy , 2011, Advanced materials.
[359] Rongqin Huang,et al. A leptin derived 30-amino-acid peptide modified pegylated poly-L-lysine dendrigraft for brain targeted gene delivery. , 2010, Biomaterials.
[360] Roger Y Tsien,et al. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[361] Xiaohu Gao,et al. Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. , 2010, Chemical Society reviews.
[362] Yu Zhang,et al. Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo. , 2011, Biomaterials.
[363] U. Nielsen,et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.
[364] Marilena Loizidou,et al. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. , 2009, Trends in pharmacological sciences.
[365] S. Rosenberg,et al. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes , 2006, Science.
[366] Warren S Warren,et al. Molecular MRI for sensitive and specific detection of lung metastases , 2010, Proceedings of the National Academy of Sciences.
[367] J. Hubbell,et al. Engineering complement activation on polypropylene sulfide vaccine nanoparticles. , 2011, Biomaterials.
[368] D Guthrie,et al. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[369] Fiona Murphy,et al. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. , 2011, Nanomedicine.
[370] Roger Y Tsien,et al. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[371] S. Bossmann,et al. Attenuation of mouse melanoma by A/C magnetic field after delivery of bi-magnetic nanoparticles by neural progenitor cells. , 2010, ACS nano.
[372] Zhichuan J. Xu,et al. Synthesis, Functionalization, and Biomedical Applications of Multifunctional Magnetic Nanoparticles , 2010, Advanced materials.
[373] J. West,et al. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. , 2007, Nano letters.
[374] M. Andreeff,et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. , 2005, Cancer research.
[375] S. Sahoo,et al. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. , 2005, Molecular pharmaceutics.
[376] Samuel Achilefu,et al. Targeting of alpha(nu)beta(3)-integrins expressed on tumor tissue and neovasculature using fluorescent small molecules and nanoparticles. , 2010, Nanomedicine.
[377] Donghoon Lee,et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. , 2008, Small.
[378] W. Hennink,et al. Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[379] S. Cannistra. Cancer of the ovary. , 1993, The New England journal of medicine.
[380] L. Rajendran,et al. Subcellular targeting strategies for drug design and delivery , 2010, Nature Reviews Drug Discovery.
[381] Gang Liu,et al. FUNCTIONAL NANOPARTICLES FOR MOLECULAR IMAGING GUIDED GENE DELIVERY. , 2010, Nano today.
[382] P. Wust,et al. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles , 1999 .
[383] P. Steeg,et al. Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer , 2010, Clinical Cancer Research.
[384] Han-Chung Wu,et al. Single chain anti-c-Met antibody conjugated nanoparticles for in vivo tumor-targeted imaging and drug delivery. , 2011, Biomaterials.
[385] M. Stevens,et al. Engineering nanocomposite materials for cancer therapy. , 2010, Small.
[386] Kenneth C. Anderson,et al. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets , 2007, Nature Reviews Cancer.
[387] Gérard Férey,et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. , 2010, Nature materials.
[388] Yadong Yin,et al. Colloidal nanocrystal synthesis and the organic–inorganic interface , 2005, Nature.
[389] Jinwoo Cheon,et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.
[390] Sushama Talegaonkar,et al. Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation. , 2009, Drug discovery today.
[391] K Kostarelos,et al. Promises, facts and challenges for carbon nanotubes in imaging and therapeutics. , 2009, Nature nanotechnology.
[392] Wenbin Lin,et al. Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. , 2008, Journal of the American Chemical Society.
[393] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.
[394] Shiladitya Sengupta,et al. Shape effect of carbon nanovectors on angiogenesis. , 2010, ACS nano.
[395] D. Curiel,et al. Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses , 2006, Molecular Cancer Therapeutics.
[396] Shuming Nie,et al. Semiconductor nanocrystals: structure, properties, and band gap engineering. , 2010, Accounts of chemical research.
[397] J. Connors,et al. State-of-the-art therapeutics: Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[398] Peter C M van Zijl,et al. MR tracking of transplanted cells with “positive contrast” using manganese oxide nanoparticles , 2008, Magnetic resonance in medicine.
[399] Bernadette Erokwu,et al. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. , 2009, Biomaterials.
[400] M. Gottesman,et al. Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.